ARECOR THERAPEUTICS PLC (AREC) — research page
UK · uk-cm-kg/AIM/AREC · as of 2026-11-06
Identity and listing
The issuer is ARECOR THERAPEUTICS PLC, listed on AIM under ticker AREC, with ISIN GB00BMWLM973 and LEI 98450093D12I3A8DDD58. Its security type is Corporate, its segment is ASQ1, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | ARECOR THERAPEUTICS PLC | source · 2026-11-06 |
| exchange | AIM | source · 2026-11-06 |
| ticker | AREC | source · 2026-11-06 |
| ISIN | GB00BMWLM973 | source · 2026-11-06 |
| LEI | 98450093D12I3A8DDD58 | source · 2026-11-09 |
| security type | Corporate | source · 2026-11-06 |
| segment | ASQ1 | source · 2026-11-06 |
| sector | Pharmaceuticals and Biotechnology [201030] | source · 2026-11-06 |
| jurisdiction | England and Wales (Companies House jurisdiction field) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 26 filings in the twelve months to 2026-11-06, across 22 filing days. The median gap between filing days is 7 days. The latest filing is dated 2026-10-15, a regulatory announcement, 22 days before the record date. The exchange median for AIM is 7.0 days of cadence across 594 issuers, with a median of 33.5 filings and a median latency of 4 days. The sector median for Pharmaceuticals and Biotechnology [201030] is 6.0 days of cadence across 51 issuers, with a median of 42 filings and a median latency of 4.0 days. The issuer's 26 filings are below the exchange median and below the sector median.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 26 | 7 | 22 |
| exchange median: AIM (594 issuers) | 33.5 | 7 | 4 |
| sector median: Pharmaceuticals and Biotechnology [201030] (51 issuers) | 42 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-15 | regulatory_announcement | Patents for concentrated ultra-rapid insulins | |
| 2026-10-14 | ch_capital | capital allotment shares — 2026-10-08 | |
| 2026-10-13 | early_warning | Holding(s) in Company | |
| 2026-10-13 | early_warning | Holding(s) in Company | |
| 2026-10-08 | early_warning | Holding(s) in Company |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is PKF Littlejohn LLP. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.
Orderability
The outcome for elective professional client is ACM-200, determinable. The outcome for eligible counterparty is ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| elective professional client | ACM-200 |
| eligible counterparty | ACM-200 |
rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The field has not been read. The number of research houses named on the issuer's investor-relations page is not on the record.
Open research
The field has not been read. The number of openly published research notes is not on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed. The market's earliest sealed date is not on the record. The live record began 2026-09-11. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed.
Sources
10 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
- 10.2
- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/AREC (identity.isin)
- 10.3
- https://find-and-update.company-information.service.gov.uk/company/13331147 (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://www.londonstockexchange.com/stock/AREC/arecor-therapeutics-plc/company-page (identity.sector)
- 10.6
- https://mcp.uk-cm-kg.ai/events/AIM/AREC (the disclosure lines)
- 10.7
- https://marketsecurities.fca.org.uk/officiallist (the halt flag)
- 10.8
- https://arecor.com/wp-content/uploads/2025/05/270269-Arecor-Therapeutics-AR-WEB.pdf (the auditor)
- 10.9
- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.10
- https://mcp.uk-cm-kg.ai/record/AIM/AREC (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"GB00BMWLM973"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:a0e9f1623c3433c7.